Invocare

InvoCare is under Algo Engine buy conditions.

In mid-April IVC announced up to $250m equity raising
at $10.40/share.

You’re not a member!  Trial today

April revenue was down 13% and we’re seeing costs higher than
anticipated. Improvement in trading conditions should occur as the partial easing of restrictions take place.

We assume 2020 earnings will be down 10% and see a recovery into 2021 & 2022.

We’ll revisit IVC if it trades back below $10.00

Ready to elevate your investing?

Join Investor Signals today and start your journey to better, more disciplined returns.